Kinase Inhibitors in Drug-design, Drug-discovery, and Drug-delivery

Vikas      Sharma

doi:10.2174/092986733013230112163412

[1]
Kumar, V.; Kaur, N.; Sahu, S.; Sharma, V.; Kumar, D.; Sharma, A.; Wadhwa, P. Role of Tyrosine kinases and their inhibitors in cancer therapy: A comprehensive review. Curr. Med. Chem.,  2023, 30(13), 1464-1481.

[2]
Indermun, S.; Kumar, P.; Govender, M.; Choonara, Y.E. Can nanomedicinal approaches provide an edge to the efficacy of tyrosine kinase inhibitors? Curr. Med. Chem.,  2023, 30(13), 1482-1501.

[3]
Al-Huseini, I.; Sirasanagandla, S.R.; Babu, K.S.; Sofin, R.G.S.; Das, S. Kinase inhibitors involved in the regulation of autophagy: Molecular concepts and clinical implications. Curr. Med. Chem.,  2023, 30(13), 1502-1528.

[4]
Prasher, P.; Sharma, M.; Chan, Y.; Singh, S.K.; Anand, K.; Dureja, H.; Jha, N.K.; Gupta, G.; Zacconi, F.; Chellappan, D.K.; Dua, K. Recent trends in rationally designed molecules as kinase inhibitors. Curr. Med. Chem.,  2023, 30(13), 1529-1567.

Download Options

Rights & Permissions Print Cite

Current Medicinal Chemistry

Title:Kinase Inhibitors in Drug-design, Drug-discovery, and Drug-delivery

Volume: 30 Issue: 13

Author(s): Vikas Sharma

Affiliation:

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

Sharma Vikas, Kinase Inhibitors in Drug-design, Drug-discovery, and Drug-delivery, Current Medicinal Chemistry 2023; 30 (13) . https://dx.doi.org/10.2174/092986733013230112163412

DOI https://dx.doi.org/10.2174/092986733013230112163412	Print ISSN 0929-8673
Publisher Name Bentham Science Publisher	Online ISSN 1875-533X

About this journal

Call for Papers in Thematic Issues

Submission closes on : 31 December, 2024

Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.

The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more

Guest Editor(s): Dr. Geir Bjørklund

Submission closes on : 31 December, 2024

Approaches to the treatment of chronic inflammation

Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more

Guest Editor(s): Dr. Vladimir Rogovskii

Submission closes on : 10 November, 2024

Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications

The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more

Guest Editor(s): Dr. Igor A. Sobenin

Submission closes on : 30 September, 2024

Chalcogen-modified nucleic acid analogues

Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more

Guest Editor(s): Dr. Katarzyna Kulik